Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)
- 15 January 2005
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 95 (2), 254-257
- https://doi.org/10.1016/j.amjcard.2004.09.013
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Review: Use of nicotinic acid in patients with elevated fasting glucose, diabetes, or metabolic syndromeBritish Journal of Diabetes, 2004
- Niacin as a Component of Combination Therapy for DyslipidemiaMayo Clinic Proceedings, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectThe New England Journal of Medicine, 1980
- The Prognostic Importance of Plasma Glucose Levels and of the Use of Oral Hypoglycemic Drugs After Myocardial Infarction in MenDiabetes, 1977
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975
- The Coronary Drug ProjectCirculation, 1973
- Regression Models and Life‐TablesJournal of the Royal Statistical Society: Series B (Methodological), 1972